Chair Jin Yang-gon of the HLB Group will step down as CEO of the group's anticancer drug developer HLB. Kim Hong-cheol, CEO and president of HLB Innovation, has been nominated as HLB's new head. HLB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results